Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Osilodrostat curbs hypercortisolism in most patients with adrenal CS

Osilodrostat curbs hypercortisolism in most patients with adrenal CS

29 Jul 2026 bởiStephen Padilla

Use of osilodrostat is effective at controlling hypercortisolism in one of three (66.7 percent) patients with adrenal Cushing's syndrome (CS) treated for longer than 4 weeks and in nearly four of five (87.5 percent) individuals treated for more than 12 weeks, a real-world study has shown. It also displays a positive impact on blood pressure and body weight.

29 Jul 2026
Which anti-obesity drug is safest, most effective?

Which anti-obesity drug is safest, most effective?

27 Jul 2026 bởiStephen Padilla

Among available drugs for obesity, tirzepatide and cagrilintide-semaglutide (CagriSema) yield the largest decrease in body weight, regardless of diabetes status, suggest the results of a systematic review and network meta-analysis.

27 Jul 2026